CHERUB (Collaborative HIV Eradication of viral Reservoirs: UK BRC) is a new approach to HIV therapeutics in the UK. CHERUB will be one of the first cooperatives of UK Biomedical Research Centers to engage internationally in one of the most exciting new fields of biomedical research – that of HIV Cure.
Internationally-recognised researchers from five Biomedical Research Centers are working together to provide a unique experimental medicine approach to new HIV therapeutic strategies. CHERUB will be the UK’s flagship in this field, bringing together, amongst others, clinicians, virologists, immunologists, molecular biologists and mathematical modellers under the umbrella of the National Institute of Health Research.
The aim of the CHERUB collaboration is to:
- Develop and promote a coordinated UK-wide response to the need to explore strategies targeting HIV eradication and remission.
- Create a biobank of samples for use in scientific research by the collaborative parties, according to agreed study protocols.
- Undertake internationally competitive clinical and scientific research within a framework for sharing of data, resources and consumables.
Follow CHERUB on Twitter: @ukcherub